Drug intelligence / Profile preview

Myrrhinil-Intest

Development stage
Unknown
Lead developer
Repha
Administration
Oral
01

Overview

**Myrrhinil-Intest** is an oral traditional herbal medicinal product developed and manufactured by Repha for supportive treatment of gastrointestinal disorders with nonspecific diarrhea accompanied by mild cramping and flatulence. Each coated tablet contains myrrh 100 mg, coffee charcoal 50 mg, and chamomile flower dry extract 70 mg. The heterogeneous botanical combination has antidiarrheal, anti-inflammatory, antispasmodic, adsorptive, and intestinal barrier-stabilizing activities, although it has no single validated molecular target. It has been evaluated in a completed Phase IV ulcerative-colitis remission-maintenance study and is being studied in a placebo-controlled Phase IV trial in diarrhea-predominant irritable bowel syndrome.

Other names
chamomile flower extract + coffee charcoal + myrrhmyrrh + chamomile extract + coffee charcoalmyrrh + coffee charcoal + chamomile flower extract

Beyond the preview

Go deeper on Myrrhinil-Intest.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myrrhinil-Intest.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call